Jay S. Duker - Net Worth and Insider Trading
Jay S. Duker Net Worth
The estimated net worth of Jay S. Duker is at least $20,353 dollars as of 2024-11-10. Jay S. Duker is the Director of EyePoint Pharmaceuticals Inc and owns about 1,750 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $20,353. Details can be seen in Jay S. Duker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay S. Duker has not made any transactions after 2019-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jay S. Duker
Jay S. Duker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jay S. Duker owns 3 companies in total, including Sesen Bio Inc (SESN) , EyePoint Pharmaceuticals Inc (EYPT) , and CARISMA Therapeutics Inc (CARM) .
Click here to see the complete history of Jay S. Duker’s form 4 insider trades.
Insider Ownership Summary of Jay S. Duker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SESN | Sesen Bio Inc | 2015-01-20 | director |
| EYPT | EyePoint Pharmaceuticals Inc | 2019-04-01 | director |
| CARM | CARISMA Therapeutics Inc | 2015-01-20 | director |
Jay S. Duker Latest Holdings Summary
Jay S. Duker currently owns a total of 1 stock. Jay S. Duker owns 1,750 shares of EyePoint Pharmaceuticals Inc (EYPT) as of April 1, 2019, with a value of $20,353.
Latest Holdings of Jay S. Duker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2019-04-01 | 1,750 | 11.63 | 20,353 |
Holding Weightings of Jay S. Duker
Jay S. Duker Form 4 Trading Tracker
According to the SEC Form 4 filings, Jay S. Duker has made a total of 0 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 500 shares on April 1, 2019, which cost Jay S. Duker around $9,450.
Insider Trading History of Jay S. Duker
- 1
Jay S. Duker Trading Performance
GuruFocus tracks the stock performance after each of Jay S. Duker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jay S. Duker is -2.84%. GuruFocus also compares Jay S. Duker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jay S. Duker within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jay S. Duker's insider trading performs compared to the benchmark.
Performance of Jay S. Duker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.11 | | | | | |
| Relative Return to S&P 500(%) | -7.08 | | | | | |
Jay S. Duker Ownership Network
Ownership Network List of Jay S. Duker
Ownership Network Relation of Jay S. Duker
Jay S. Duker Owned Company Details
What does Sesen Bio Inc do?
Who are the key executives at Sesen Bio Inc?
Jay S. Duker is the director of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .
Sesen Bio Inc (SESN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sesen Bio Inc Insider Transactions
Jay S. Duker Mailing Address
Above is the net worth, insider trading, and ownership report for Jay S. Duker. You might contact Jay S. Duker via mailing address: C/o Eleven Biotherapeutics, 215 1st St. #400, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
